Advanced search
Publication Cover
International Reviews of Immunology Volume 34, 2015 - Issue 2
Submit an article Journal homepage
3,791
Views
55
CrossRef citations to date
0
Altmetric
REVIEWS

Chimeric Antigen Receptor Engineering: A Right Step in the Evolution of Adoptive Cellular Immunotherapy

Jose A. FigueroaDivision of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA;Kiromic, LLC, Lubbock, Lubbock, TX, USA
,
Adair ReidyDivision of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA;Kiromic, LLC, Lubbock, Lubbock, TX, USA
,
Leonardo MirandolaDivision of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA;Kiromic, LLC, Lubbock, Lubbock, TX, USA;The Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Texas Tech University Health Sciences Center, Amarillo, TX, USA
,
Kayley TrotterDivision of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA;Kiromic, LLC, Lubbock, Lubbock, TX, USA
,
Natallia SuvoravaDivision of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA
,
Alejandro FigueroaDivision of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA;Kiromic, LLC, Lubbock, Lubbock, TX, USA
,
Venu KonalaDivision of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA
,
Amardeep AulakhDivision of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA
,
Lauren LittlefieldDivision of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA
,
Fabio GrizziHumanitas Clinical and Research Center, Milan, Italy
,
Rakhshanda Layeequr RahmanDivision of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA
,
Marjorie R. JenkinsThe Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Texas Tech University Health Sciences Center, Amarillo, TX, USA
,
Breeanna MusgroveDivision of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA;Kiromic, LLC, Lubbock, Lubbock, TX, USA
,
Saba RadhiDivision of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA
,
Nicholas D'CunhaDivision of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA
,
Luke N. D'CunhaDivision of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA
,
Paul L. HermonatUniversity of Arkansas Medical Sciences, Little Rock, AR, USA
,
Everardo CobosDivision of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA;Kiromic, LLC, Lubbock, Lubbock, TX, USA
&
Maurizio Chiriva-InternatiDivision of Hematology and Oncology, Texas Tech University Health Sciences Center, Lubbock, TX, USA;Kiromic, LLC, Lubbock, Lubbock, TX, USA;The Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Texas Tech University Health Sciences Center, Amarillo, TX, USA;The Laura W. Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Texas Tech University Health Sciences Center, Amarillo, TX, USACorrespondence[email protected]
 show all
Pages 154-187 | Accepted 09 Feb 2015, Published online: 22 Apr 2015

Citations (55)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jiong Chen, Hong Xu & Xing-Xing Zhu. (2016) Abnormal expression levels of sMICA and NKG2D are correlated with poor prognosis in pancreatic cancer. Therapeutics and Clinical Risk Management 12, pages 11-18.
Read now

Articles from other publishers (54)

Milena Urbini, Sara Bleve, Giuseppe Schepisi, Cecilia Menna, Giorgia Gurioli, Caterina Gianni & Ugo De Giorgi. (2023) Biomarkers for Salvage Therapy in Testicular Germ Cell Tumors. International Journal of Molecular Sciences 24:23, pages 16872.
Crossref
Yuxin Zhou, Wenjing Mu, Chen Wang, Zipeng Zhuo, Yu Xin, Hongxu Li & Changsong Wang. (2023) Ray of dawn: Anti-PD-1 immunotherapy enhances the chimeric antigen receptor T-cell therapy in Lymphoma patients. BMC Cancer 23:1.
Crossref
Bryan Gardam, Tessa Gargett, Michael P. Brown & Lisa M. Ebert. (2023) Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastoma. Frontiers in Immunology 14.
Crossref
K. Devaraja, Sadhna Aggarwal & Manisha Singh. (2023) Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma—A Review. Vaccines 11:3, pages 634.
Crossref
Prajish Iyer & Lili Wang. (2023) Emerging Therapies in CLL in the Era of Precision Medicine. Cancers 15:5, pages 1583.
Crossref
Giuseppe Schepisi, Caterina Gianni, Maria Concetta Cursano, Valentina Gallà, Cecilia Menna, Chiara Casadei, Sara Bleve, Cristian Lolli, Giovanni Martinelli, Giovanni Rosti & Ugo De Giorgi. (2023) Immune checkpoint inhibitors and Chimeric Antigen Receptor (CAR)-T cell therapy: Potential treatment options against Testicular Germ Cell Tumors. Frontiers in Immunology 14.
Crossref
Hairong Fei, Xiaodan Liu, Lingjie Sun, Xue Shi, Wei Wang, Hongguo Zhao & Chunting Zhao. (2022) Disseminated fusarium infection after allogeneic hematopoietic stem cell transplantation after CART: A case report. Medicine 101:45, pages e31594.
Crossref
Bingzhe LV, Yunpeng Wang, Dongjiang Ma, Wei Cheng, Jie Liu, Tao Yong, Hao Chen & Chen Wang. (2022) Immunotherapy: Reshape the Tumor Immune Microenvironment. Frontiers in Immunology 13.
Crossref
Rilan Bai & Jiuwei Cui. (2022) Development of Immunotherapy Strategies Targeting Tumor Microenvironment Is Fiercely Ongoing. Frontiers in Immunology 13.
Crossref
Francesca Perutelli, Rebecca Jones, Valentina Griggio, Candida Vitale & Marta Coscia. (2022) Immunotherapeutic Strategies in Chronic Lymphocytic Leukemia: Advances and Challenges. Frontiers in Oncology 12.
Crossref
Derek P. Wong, Nand K. Roy, Keman Zhang, Anusha Anukanth, Abhishek Asthana, Nicole J. Shirkey-Son, Samantha Dunmire, Bryan J. Jones, Walker S. Lahr, Beau R. Webber, Branden S. Moriarity, Paolo Caimi & Reshmi Parameswaran. (2022) A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers. Nature Communications 13:1.
Crossref
Tae Jin Kim, Young Hwa Lee & Kyo Chul Koo. (2022) Current and future perspectives on CAR-T cell therapy for renal cell carcinoma: A comprehensive review. Investigative and Clinical Urology 63:5, pages 486.
Crossref
Bilquees, Humira Jeelani, Nahida Tabasum & Faheem Hyder Pottoo. 2022. A Molecular Approach to Immunogenetics. A Molecular Approach to Immunogenetics 327 346 .
Teng Hou, Tianqi Wang, Weiwei Mu, Rui Yang, Shuang Liang, Zipeng Zhang, Shunli Fu, Tong Gao, Yongjun Liu & Na Zhang. (2020) Nanoparticle-Loaded Polarized-Macrophages for Enhanced Tumor Targeting and Cell-Chemotherapy. Nano-Micro Letters 13:1.
Crossref
Yujie Li, Dengqiang Wu, Xuejia Yang & Sufang Zhou. (2021) Immunotherapeutic Potential of T Memory Stem Cells. Frontiers in Oncology 11.
Crossref
Aymara Sancho-Araiz, Victor Mangas-Sanjuan & Iñaki F. Trocóniz. (2021) The Role of Mathematical Models in Immuno-Oncology: Challenges and Future Perspectives. Pharmaceutics 13:7, pages 1016.
Crossref
S. Tahmasebi, R. Elahi, E. Khosh & A. Esmaeilzadeh. (2020) Programmable and multi-targeted CARs: a new breakthrough in cancer CAR-T cell therapy. Clinical and Translational Oncology 23:6, pages 1003-1019.
Crossref
Zilong Guo, Yirui Zhang, Mingpeng Fu, Liang Zhao, Zhen Wang, Zhuoshuo Xu, Huifen Zhu, Xiaoli Lan, Guanxin Shen, Yong He & Ping Lei. (2021) The Transferrin Receptor-Directed CAR for the Therapy of Hematologic Malignancies. Frontiers in Immunology 12.
Crossref
Shilu Mathew, Muhammed Faheem, Neeraja A. Hassain, Fatiha M. Benslimane, Asmaa A. Al Thani, Hassan Zaraket & Hadi M. Yassine. (2020) Platforms Exploited for SARS-CoV-2 Vaccine Development. Vaccines 9:1, pages 11.
Crossref
Nashwa El-Khazragy, Sherief Ghozy, Passant Emad, Mariam Mourad, Diaaeldeen Razza, Yasmeen K Farouk, Nermeen A Mohamed, Mohamed K Ahmed, Tarek Youssef, Youssef M Bahnasawy & Shereen Elmasery. (2020) Chimeric antigen receptor T cells immunotherapy: challenges and opportunities in hematological malignancies. Immunotherapy 12:18, pages 1341-1357.
Crossref
Giuseppe Schepisi, Vincenza Conteduca, Chiara Casadei, Giorgia Gurioli, Lorena Rossi, Valentina Gallà, Maria Concetta Cursano, Nicole Brighi, Cristian Lolli, Cecilia Menna, Alberto Farolfi, Salvatore Luca Burgio, Amelia Altavilla, Giovanni Martinelli & Ugo De Giorgi. (2020) Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors. Frontiers in Oncology 10.
Crossref
Cody Barbari, Tyler Fontaine, Priyanka Parajuli, Narottam Lamichhane, Silvia Jakubski, Purushottam Lamichhane & Rahul R. Deshmukh. (2020) Immunotherapies and Combination Strategies for Immuno-Oncology. International Journal of Molecular Sciences 21:14, pages 5009.
Crossref
Geoffrey Parriott, Kelsey Deal, Shane Crean, Elle Richardson, Emily Nylen & Amorette Barber. (2020) T‐cells expressing a chimeric‐PD1‐Dap10‐CD3zeta receptor reduce tumour burden in multiple murine syngeneic models of solid cancer. Immunology 160:3, pages 280-294.
Crossref
Wenting Song & Mingzhi Zhang. (2020) Use of CAR-T cell therapy, PD-1 blockade, and their combination for the treatment of hematological malignancies. Clinical Immunology 214, pages 108382.
Crossref
Akram Al AbbarSiew Ching NgaiNadine NogralesSuleiman Yusuf AlhajiSyahril Abdullah. (2020) Induced Pluripotent Stem Cells: Reprogramming Platforms and Applications in Cell Replacement Therapy. BioResearch Open Access 9:1, pages 121-136.
Crossref
Mohammadmahdi Sabahi, Parnian Jabbari, Milad Alizadeh Haghighi, Setare Soltani, Sara Soudi, Farzaneh Rahmani & Nima Rezaei. (2020) Proposing a tandem AND-gate CAR T cell targeting glioblastoma multiforme. Medical Hypotheses 137, pages 109559.
Crossref
Qingyang Zhang, Jieming Ping, Zirui Huang, Xiaoli Zhang, Jingyi Zhou, Gangyang Wang, Shaoyang Liu & Jianjun Ma. (2020) CAR-T Cell Therapy in Cancer: Tribulations and Road Ahead. Journal of Immunology Research 2020, pages 1-11.
Crossref
Pichaya Thanindratarn, Dylan C. Dean, Scott D. Nelson, Francis J. Hornicek & Zhenfeng Duan. (2020) Chimeric antigen receptor T (CAR-T) cell immunotherapy for sarcomas: From mechanisms to potential clinical applications. Cancer Treatment Reviews 82, pages 101934.
Crossref
Jean-François Rossi, Patrice Céballos & Zhao-Yang Lu. (2019) Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells. Cancer Communications 39:1, pages 34.
Crossref
Li Yi, Yin Weifan & Yang Huan. (2019) Chimeric antigen receptor–engineered regulatory T lymphocytes: promise for immunotherapy of autoimmune disease. Cytotherapy 21:9, pages 925-934.
Crossref
Kavitha Gowrishankar, Lucy Birtwistle & Kenneth Micklethwaite. (2018) Manipulating the tumor microenvironment by adoptive cell transfer of CAR T-cells. Mammalian Genome 29:11-12, pages 739-756.
Crossref
Matthew J. Buettner, Sagar R. Shah, Christopher T. Saeui, Ryan Ariss & Kevin J. Yarema. (2018) Improving Immunotherapy Through Glycodesign. Frontiers in Immunology 9.
Crossref
Ye Li, David L. Hermanson, Branden S. Moriarity & Dan S. Kaufman. (2018) Human iPSC-Derived Natural Killer Cells Engineered with Chimeric Antigen Receptors Enhance Anti-tumor Activity. Cell Stem Cell 23:2, pages 181-192.e5.
Crossref
Yang Chen, Chang-Yong E, Zhi-Wen Gong, Shui Liu, Zhen-Xiao Wang, Yong-Sheng Yang & Xue-Wen Zhang. (2018) Chimeric antigen receptor-engineered T-cell therapy for liver cancer. Hepatobiliary & Pancreatic Diseases International 17:4, pages 301-309.
Crossref
Reza Elahi, Elnaz Khosh, Safa Tahmasebi & Abdolreza Esmaeilzadeh. (2018) Immune Cell Hacking: Challenges and Clinical Approaches to Create Smarter Generations of Chimeric Antigen Receptor T Cells. Frontiers in Immunology 9.
Crossref
Debra D. Bloom, Sofiya Reshetylo, Cassandra Nytes, Claudia T. Goodsett & Peiman Hematti. (2018) Blockade of BAFF Receptor BR3 on T Cells Enhances Their Activation and Cytotoxicity. Journal of Immunotherapy 41:5, pages 213-223.
Crossref
Charlotte de Wolf, Marja van de Bovenkamp & Marcel Hoefnagel. (2018) Regulatory perspective on in vitro potency assays for human T cells used in anti-tumor immunotherapy. Cytotherapy 20:5, pages 601-622.
Crossref
Morgan Pantuck, Nicolaos Palaskas & Alexandra Drakaki. (2018) Next generation T-cell therapy for genitourinary malignancies, part B: Overcoming obstacles and future strategies for success. Cancer Treatment and Research Communications 17, pages 1-7.
Crossref
Morgan Pantuck, Nicolaos Palaskas & Alexandra Drakaki. (2018) Next generation T-cell therapy for genitourinary malignancies, part A: Introduction and current state of the art. Cancer Treatment and Research Communications 17, pages 8-12.
Crossref
William R. Strohl. (2017) Current progress in innovative engineered antibodies. Protein & Cell 9:1, pages 86-120.
Crossref
Ping-Pin Zheng, Jin Li & Johan M Kros. (2018) Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights. Medicinal Research Reviews 38:1, pages 325-376.
Crossref
Erhao Zhang & Hanmei Xu. (2017) A new insight in chimeric antigen receptor-engineered T cells for cancer immunotherapy. Journal of Hematology & Oncology 10:1.
Crossref
Jinjing Xu, Qing Zhang, Kang Tian, Haiyu Wang, Hong Yin & Junnian Zheng. (2017) Current status and future prospects of the strategy of combining CAR‑T with PD‑1 blockade for antitumor therapy (Review). Molecular Medicine Reports.
Crossref
Xinxin Zhu, Han Cai, Ling Zhao, Li Ning & Jinghe Lang. (2017) CAR-T cell therapy in ovarian cancer: from the bench to the bedside. Oncotarget 8:38, pages 64607-64621.
Crossref
Cody S. Lee, Elliot S. Bishop, Ruyi Zhang, Xinyi Yu, Evan M. Farina, Shujuan Yan, Chen Zhao, Zongyue Zeng, Yi Shu, Xingye Wu, Jiayan Lei, Yasha Li, Wenwen Zhang, Chao Yang, Ke Wu, Ying Wu, Sherwin Ho, Aravind Athiviraham, Michael J. Lee, Jennifer Moriatis Wolf, Russell R. Reid & Tong-Chuan He. (2017) Adenovirus-mediated gene delivery: Potential applications for gene and cell-based therapies in the new era of personalized medicine. Genes & Diseases 4:2, pages 43-63.
Crossref
Jie-Ying Xu, Zhen-Long Ye, Du-Qing Jiang, Jiang-Chuan He, Yong-Mei Ding, Lin-Fang Li, Sai-Qun Lv, Ying Wang, Hua-Jun Jin & Qi-Jun Qian. (2017) Mesothelin-targeting chimeric antigen receptor–modified T cells by piggyBac transposon system suppress the growth of bile duct carcinoma . Tumor Biology 39:4, pages 101042831769594.
Crossref
Wei Han, Wei Li, Xiaoying Zhang, Zhonghua Du, Xiaoliang Liu, Xin Zhao, Xue Wen, Guanjun Wang, Ji-Fan Hu & Jiuwei Cui. (2017) Targeted breast cancer therapy by harnessing the inherent blood group antigen immune system. Oncotarget 8:9, pages 15034-15046.
Crossref
Russell E. VanceMichael J. EichbergDaniel A. PortnoyDavid H. Raulet. (2017) Listening to each other: Infectious disease and cancer immunology. Science Immunology 2:7.
Crossref
Johan Garssen & Juandy Jo. (2017) Genetically-engineered T cells to treat viral hepatitis-associated liver cancer: is it possible?. AIMS Allergy and Immunology 1:1, pages 43-49.
Crossref
Lucia Signorini, Serena Delbue, Pasquale Ferrante & Marco Bregni. (2016) Review on the immunotherapy strategies against metastatic colorectal carcinoma. Immunotherapy 8:10, pages 1245-1261.
Crossref
Hua Pan, Aram Gazarian, Jean-Michel Dubernard, Alexandre Belot, Marie-Cécile Michallet & Mauricette Michallet. (2016) Transplant Tolerance Induction in Newborn Infants: Mechanisms, Advantages, and Potential Strategies. Frontiers in Immunology 7.
Crossref
Bryan McQueen, Kelsey Trace, Emily Whitman, Taylor Bedsworth & Amorette Barber. (2016) Natural killer group 2D and CD 28 receptors differentially activate mammalian/mechanistic target of rapamycin to alter murine effector CD 8 + T‐cell differentiation . Immunology 147:3, pages 305-320.
Crossref
Kesang Li, Xiaorong Pan, Yanyu Bi, Wen Xu, Cheng Chen, Huiping Gao, Bizhi Shi, Hua Jiang, Shengli Yang, Liyan Jiang & Zonghai Li. (2015) Adoptive immunotherapy using T lymphocytes redirected to glypican-3 for the treatment of lung squamous cell carcinoma. Oncotarget 7:3, pages 2496-2507.
Crossref
A. Tsun, X. N. Miao, C. M. Wang & D. C. Yu. 2016. Progress in Cancer Immunotherapy. Progress in Cancer Immunotherapy 241 283 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.